Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new Revision: v3.4.3 to the record history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history and a government operating-status notice was removed; no core study data or status information was modified.
    Difference
    0.9%
    Check dated 2026-02-11T12:34:26.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added a site-wide funding notice about government lapse and operating status; updated version to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T10:14:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option, uses green/red highlights to indicate additions and deletions, and updates the revision tag to v3.4.0 while removing older items like No FEAR Act data and v3.3.4.
    Difference
    1%
    Check dated 2026-01-28T06:08:22.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Version history now shows a new revision entry v3.3.4 and removes v3.3.3 from the history. This is a minor metadata update that does not affect current study details such as recruitment status or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:24:13.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history. The 'HHS Vulnerability Disclosure' link and the prior 'Revision: v3.3.2' entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:28:59.000Z thumbnail image

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.